Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Immatics appoints CEO

Harpreet Singh was named CEO of Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies.

Read More »

Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company

Clinical-stage biopharmaceutical company Gemphire Therapeutics Inc. and privately held clinical-stage biotechnology company NeuroBo Pharmaceuticals Inc. jointly announced a definitive agreement whereby NeuroBo will merge with a wholly owned subsidiary of Gemphire in an all-stock transaction.

Read More »

RI Bio Interview: Rhode Island Sets the Stage for Long-Term Life Sciences Growth

While Boston tends to get the lion’s share of recognition as the premier biopharma hub on the East Coast of the United States, other cities and states are looking to make their names known as a strong location for the industry. New Jersey, New York and New Hampshire have gone to great lengths to distinguish themselves, but so too has smaller Rhode Island.

Read More »

Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain

Cryoport Inc. and EVERSANA announced a strategic alliance to further create a fully integrated regenerative medicine supply chain solution.

Read More »

Gilead, Lyndra to Develop Long-Acting HIV Therapies

Lyndra Therapeutics and Gilead Sciences entered a partnership collaboration to develop and market ultra-long-acting oral HIV therapies.

Read More »

Pitango Venture Capital launches $150 million health technology fund

Israel’s Pitango Venture Capital is launching a fund that will reach $150 million to invest in health technology.

Read More »

IQVIA Report: Biopharma R&D Investment Increased 32 Percent Over Last 5 Years

The IQVIA report finds that in 2018, 27% of drugs launched were for cancer or its symptoms, and 20% were for infectious diseases.

Read More »

March Madness: “The Fabulous 5” Life Science IPOs

March 2019 was a busy month for biopharma and medical device company initial public offerings.

Read More »

“Golden Girls” Mice Are Key to Longevity Research

There has been a heightened interest in longevity research. Some have noted that older billionaires such as Bill Gates, Michael Bloomberg, Richard Branson and others have been investing heavily into biopharma companies focused on aging and aging-related diseases.

Read More »

Women’s History Month: Top Influential Women in Biopharma

March is National Women’s Month, and BioSpace recognized these 10 women as being especially influential in the biopharma industry.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom